PubMed:32338224 / 5817-6075 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T194 109-113 PR:000001393 denotes IL-6
T195 153-164 UBERON:0001004 denotes respiratory
T196 177-184 SP_7 denotes COVID19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T55 75-84 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T56 86-97 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T57 98-104 Body_part denotes (IL)-1 http://purl.org/sig/ont/fma/fma86583
T58 99-101 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T59 109-111 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T36 8-19 Disease denotes lymphopenia http://purl.obolibrary.org/obo/MONDO_0003783
T37 177-184 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T90 115-118 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T91 254-256 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T28 99-101 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T30 109-111 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T5 8-19 Phenotype denotes lymphopenia http://purl.obolibrary.org/obo/HP_0001888

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T36 0-258 DRI_Background denotes Despite lymphopenia, evidence for an exaggerate release of proinflammatory cytokines [interleukin (IL)-1 and IL-6] has been reported in the course acute respiratory syndrome in COVID19 infected patients, thus, aggravating the clinical course of disease [34].

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T36 0-258 Sentence denotes Despite lymphopenia, evidence for an exaggerate release of proinflammatory cytokines [interleukin (IL)-1 and IL-6] has been reported in the course acute respiratory syndrome in COVID19 infected patients, thus, aggravating the clinical course of disease [34].